Pharmaceutical Industry Information Portal

HomeTop

Top

Code Biotherapeutics raises $75 Million to advance programs to treat and cure rare and prevalent genetic diseases

Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized and oversubscribed Series A financing...

Bristol Myers Squibb announces a $4.1 billion deal to acquire Turning Point Therapeutics

Pharmaceutical giant Bristol Myers Squibb Company announced a $4.1 billion deal for Turning Point Therapeutics Inc  on Friday morning, the first sizable acquisition for...

Klimaoprema announces new brand Amelicor

Klimaoprema’s business, growth, and potential make us a reliable partner in the world, as evidenced by the fact that more than 90% of our...

Bavarian Nordic signs contract to supply smallpox vaccine due to an increase in cases of monkeypox

Bavarian Nordic A/S announced today the signing of a supply contract with an undisclosed country for the Company’s smallpox vaccine with the aim to...

Biotech startup raises $6.2 million to develop plastic-free packaging

Targeting cosmetics brands, the London-based biotech startup has scooped up a $6.2 million seed round to prove it can scale its petroleum-free, compostable packaging,...

Bayer intends to discontinue partnership with Atara on CAR-T for $670 million

Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and...
spot_img

Expert Articles

spot_img